Barclays PLC Increases Holdings in Amedisys, Inc. (NASDAQ:AMED)

Barclays PLC lifted its position in Amedisys, Inc. (NASDAQ:AMED) by 49.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,529 shares of the health services provider’s stock after buying an additional 5,142 shares during the period. Barclays PLC’s holdings in Amedisys were worth $1,500,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of AMED. Arizona State Retirement System raised its position in Amedisys by 2.0% in the second quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock worth $840,000 after acquiring an additional 177 shares during the period. Signaturefd LLC grew its position in shares of Amedisys by 20.9% during the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock valued at $132,000 after acquiring an additional 236 shares during the period. State of Alaska Department of Revenue increased its stake in shares of Amedisys by 7.2% in the 3rd quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider’s stock worth $365,000 after purchasing an additional 255 shares in the last quarter. CWM LLC raised its holdings in Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares during the period. Finally, Creative Planning lifted its position in Amedisys by 7.4% during the second quarter. Creative Planning now owns 4,295 shares of the health services provider’s stock valued at $394,000 after purchasing an additional 295 shares in the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Performance

Shares of AMED opened at $89.96 on Friday. The business has a 50-day simple moving average of $90.45 and a two-hundred day simple moving average of $94.43. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The stock has a market cap of $2.95 billion, a price-to-earnings ratio of 35.70, a PEG ratio of 1.84 and a beta of 0.73.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. During the same period in the prior year, the company posted $0.98 EPS. The company’s quarterly revenue was up 5.7% on a year-over-year basis. On average, analysts expect that Amedisys, Inc. will post 4.45 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.